What Happened?
Shares of healthcare services company Agilon Health (NYSE: AGL) fell 7.2% in the morning session after Bernstein SocGen Group lowered its price target on the stock to $0.88 from $1.40, pointing to concerns about its cash flow.
The firm noted the company was quickly burning through cash and needed to slow its revenue growth to work on a medical cost turnaround. This news added to a series of recent challenges for agilon health. The company had previously reported a larger-than-expected loss in its third-quarter earnings for 2025. Furthermore, it received a notice from the New York Stock Exchange for not meeting listing standards, as its average stock price had fallen below $1.00 over a 30-day period. To address the low stock price, agilon health stated it planned to pursue a reverse stock split, which would require stockholder approval.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy agilon health? Access our full analysis report here.
What Is The Market Telling Us
agilon health’s shares are extremely volatile and have had 71 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 14 days ago when the stock gained 18.3% on the news that comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
agilon health is down 65.1% since the beginning of the year, and at $0.67 per share, it is trading 88.2% below its 52-week high of $5.68 from April 2025. Investors who bought $1,000 worth of agilon health’s shares at the IPO in April 2021 would now be looking at an investment worth $21.65.
Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free for active Edge members and will only take you a second.
